Aller au contenu principal
Profil bibliographique

Erin Korth

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
1Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Sepsis Diagnosis and TreatmentAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICUPalliative Care and End-of-Life IssuesRespiratory Support and Mechanisms

Les publications récentes

Accès ouvert 2026 article OpenAlex

Evaluation of a Direct-from-Blood Molecular Diagnostic Platform for Pathogen Detection in Critically Ill Patients: A Prospective Observational Cohort Study

Yupeng Liu, Helen Donnelly, Alvaro Donayre, Erin Korth et autres

Rationale: Defining the microbial etiology of sepsis is difficult but has important implications for antibiotic stewardship and prognosis. We explore the diagnostic yield of a novel, direct-from-blood multiplex polymerase chain reaction in intensive care unit patients with suspected sepsis. Methods: From March …

us (code pays fourni par la source)

0 citations Open Forum Infectious Diseases
Accès ouvert 2026 article OpenAlex

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy

Adrian Valadez, Marc H Scheetz, Michael Neely, Helen K Donnelly et autres

BACKGROUND: Meropenem is widely used to treat hospital-acquired pneumonia in critically ill patients, with efficacy dependent on the time that free concentrations exceed the minimum inhibitory concentration (fT > MIC). In practice, single-sample therapeutic drug monitoring (TDM) may not ensure target attainment, …

us (code pays fourni par la source)

1 citation Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2026 article OpenAlex

271: TIME-LIMITED TRIALS: AN ETHNOGRAPHIC STUDY COMPARING WORK-AS-ENVISIONED TO WORK-AS-PERFORMED

Arsalan Ahmad, Douglas Wiegmann, Oliver Nguyen, Joy Moy et autres

Introduction: Time-limited trials (TLT) are a flexible approach to decision-making about life-sustaining therapies amid uncertainty in critically ill patients. Though increasingly used in ICUs, their conduct varies widely and is shaped by clinician judgment and context. Amidst this wide variation in practice, …

us, ch (code pays fourni par la source)

0 citations Critical Care Medicine
2026 article OpenAlex

258: EVALUATING PHYSICIAN VARIABILITY IN USE OF TIME-LIMITED TRIALS IN MECHANICALLY VENTILATED PATIENTS

Andrew Wu, Cemre Orhan, Joy Moy, Emily Campbell et autres

Introduction: A time-limited trial (TLT) is a collaborative plan among patients, surrogates, and clinicians to try life-sustaining therapy for a defined duration for critically ill patients whose prognosis is uncertain. Prior work demonstrates variability in physicians’ use of TLTs, but little is …

us, ch (code pays fourni par la source)

0 citations Critical Care Medicine
Accès ouvert 2026 article OpenAlex

P-1227. Pulmonary Target Pharmacokinetic/Pharmacodynamic Attainment Rates among Cefepime-treated Patients Admitted to the ICU with Hospital-Acquired Pneumonia requiring Renal Replacement

Adrian Valadez, Emma Harlan, Marc H. Scheetz, Helen K Donnelly et autres

Abstract Background The impact of continuous renal replacement therapy (CRRT) on cefepime (FEP) pharmacokinetics (PK) in the epithelial lining fluid (ELF) of patients with hospital-acquired pneumonia is not well described.Population PK parameters for FEP in Renal Replacement in Plasma and ELFObserved vs. …

us (code pays fourni par la source)

0 citations Open Forum Infectious Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.